High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.1M
$3,102,533
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 SellΔOwn -13.6%
|
2026-03-04 | $712,621 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-04 | $37,616 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $138,895 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $10,604 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $140,364 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $191,640 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $141,343 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $136,024 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $152,125 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $299,841 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $328,542 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $510,823 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-04 | $93,993 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2025-12-16 | $63,091 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2025-12-16 | $3,948 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2025-12-16 | $18,132 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2025-12-16 | $60,408 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2025-12-16 | $18,719 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Discretionary Sell
|
2025-12-12 | $339,711 | S | Form 4 |